Literature DB >> 12845668

Overexpression of thymidylate synthase mediates desensitization for 5-fluorouracil of tumor cells.

Yasushi Saga1, Mitsuaki Suzuki, Hiroaki Mizukami, Takahiro Kohno, Yuji Takei, Masakazu Fukushima, Keiya Ozawa.   

Abstract

The prognosis of cancers of various organs overexpressing thymidylate synthase (TS) has been reported to be poor. It has been suggested that the poor prognosis is partly due to a low sensitivity of TS-overexpressing tumors to TS-targeting 5-fluorouracil (5-FU). To investigate the relationship between TS expression and sensitivity to 5-FU, we used the TS-overexpressing cervical cancer cell line SKG-II/TS and SKG-I/TS that had been established by TS gene transfer. The 50% growth inhibitory concentration (IC(50)) of 5-FU for SKG-II/TS was 24 +/- 6.0 microM, which was 6 times as high as that for the control (4.0 +/- 1.1 microM), showing significantly decreased sensitivity to 5-FU (p < 0.01). The IC(50) of 5-FU for SKG-I/TS was 90 +/- 15 microM, which was over 2 times as high as that for the control (40 +/- 0.6 microM), showing significantly decreased sensitivity to 5-FU (p < 0.05). Thus, TS-overexpressing tumors have decreased sensitivity to 5-FU, which may be one of the factors that determine the prognosis of these tumors. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12845668     DOI: 10.1002/ijc.11221

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients.

Authors:  Tian-Li Wang; Luis A Diaz; Katharine Romans; Alberto Bardelli; Saurabh Saha; Gennaro Galizia; Michael Choti; Ross Donehower; Giovanni Parmigiani; Ie-Ming Shih; Christine Iacobuzio-Donahue; Kenneth W Kinzler; Bert Vogelstein; Christoph Lengauer; Victor E Velculescu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-17       Impact factor: 11.205

2.  Histone deacetylase inhibitors sensitize 5-fluorouracil-resistant MDA-MB-468 breast cancer cells to 5-fluorouracil.

Authors:  Tetsuya Minegaki; Ai Suzuki; Misato Mori; Shiori Tsuji; Satoshi Yamamoto; Airi Watanabe; Tomoyo Tsuzuki; Takaki Tsunoda; Asuka Yamamoto; Masayuki Tsujimoto; Kohshi Nishiguchi
Journal:  Oncol Lett       Date:  2018-09-04       Impact factor: 2.967

3.  Antisense targeting of thymidylate synthase (TS) mRNA increases TS gene transcription and TS protein: effects on human tumor cell sensitivity to TS enzyme-inhibiting drugs.

Authors:  Tracey L H Jason; Randal W Berg; Mark D Vincent; James Koropatnick
Journal:  Gene Expr       Date:  2007

4.  FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expression.

Authors:  Vidhya Varghese; Luca Magnani; Narumi Harada-Shoji; Francesco Mauri; Richard M Szydlo; Shang Yao; Eric W-F Lam; Laura M Kenny
Journal:  Sci Rep       Date:  2019-02-06       Impact factor: 4.379

Review 5.  Curcumin as an Enhancer of Therapeutic Efficiency of Chemotherapy Drugs in Breast Cancer.

Authors:  Reyhaneh Farghadani; Rakesh Naidu
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 5.923

6.  Early detection of thymidylate synthase resistance in non-small cell lung cancer with FLT-PET imaging.

Authors:  Xiao Chen; Yizeng Yang; Sharyn Katz
Journal:  Oncotarget       Date:  2017-07-31

7.  Identification of key genes and pathways of diagnosis and prognosis in cervical cancer by bioinformatics analysis.

Authors:  Hua-Ju Yang; Jin-Min Xue; Jie Li; Ling-Hong Wan; Yu-Xi Zhu
Journal:  Mol Genet Genomic Med       Date:  2020-03-17       Impact factor: 2.183

8.  MicroRNA-941 regulates the proliferation of breast cancer cells by altering histone H3 Ser 10 phosphorylation.

Authors:  Sunil Kumar Surapaneni; Zahid Rafiq Bhat; Kulbhushan Tikoo
Journal:  Sci Rep       Date:  2020-10-21       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.